{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:06:19Z","timestamp":1762340779343},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ijantimicag.2014.12.019","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T14:14:32Z","timestamp":1421763272000},"page":"427-429","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Persistent extended-spectrum \u03b2-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline"],"prefix":"10.1016","volume":"45","author":[{"given":"Burke A.","family":"Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Gran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0005","first-page":"347","article-title":"Pharmacokinetic considerations in the treatment of urinary tract infections","volume":"43","author":"Cunha","year":"1979","journal-title":"Conn Med"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0010","first-page":"443","article-title":"Antibiotic tissue penetration","volume":"59","author":"Cunha","year":"1983","journal-title":"Bull NY Acad Med"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0090-4295(82)90660-4","article-title":"Current concepts in antimicrobial therapy of prostatitis","volume":"20","author":"Ristuccia","year":"1982","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1179\/joc.2011.23.3.171","article-title":"Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations","volume":"23","author":"Cunha","year":"2011","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0090-4295(90)80201-W","article-title":"Tetracyclines in urology: current concepts","volume":"36","author":"Cunha","year":"1990","journal-title":"Urology"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.medmal.2013.01.006","article-title":"Alternatives to carbapenems in ESBL-producing Escherichia coli infections","volume":"43","author":"Fournier","year":"2013","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0040","series-title":"Antibiotic essentials","first-page":"110","author":"Cunha","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0045","series-title":"Kucers\u2019 the use of antibiotics","first-page":"935","article-title":"Fosfomycin","author":"Frimodt-M\u00f8ller","year":"2010"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0050","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/cid\/cit704","article-title":"Is fosfomycin a potential treatment alternative for multidrug-resistant Gram-negative prostatitis?","volume":"58","author":"Gardiner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0055","series-title":"Kucers\u2019 the use of antibiotics","first-page":"851","article-title":"Doxycycline","author":"Eisen","year":"2010"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/00365548.2012.734636","article-title":"High frequency of co-resistance in CTX-M-producing Escherichia coli to non-\u03b2-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden","volume":"45","author":"\u00d6stholm Balkhed","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00019048-200009090-00004","article-title":"Treatment of a complicated vancomycin-resistant enterococcal urinary tract infection with fosfomycin","volume":"9","author":"Shrestha","year":"2000","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0070","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Lipsy","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.12.019_bib0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cid\/cir838","article-title":"ESCMID Study Group for antibiotic policies. Forgotten antibiotics: an inventory in Europe, the United States, Canada and Australia","volume":"54","author":"Pulcini","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T01:56:57Z","timestamp":1537927017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0924857915000254"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.12.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent extended-spectrum \u03b2-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}